Neuropeptide Y stimulates osteoblastic differentiation and VEGF expression of bone marrow mesenchymal stem cells related to canonical Wnt signaling activating in vitro

[1]  G. Pei,et al.  Neuropeptide Substance P Improves Osteoblastic and Angiogenic Differentiation Capacity of Bone Marrow Stem Cells In Vitro , 2014, BioMed Research International.

[2]  Jian Zhou,et al.  Neuropeptide SP activates the WNT signal transduction pathway and enhances the proliferation of bone marrow stromal stem cells , 2013, Cell biology international.

[3]  D. Jackson,et al.  Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis , 2013, Peptides.

[4]  Yingze Zhang,et al.  Neuropeptides stimulate human osteoblast activity and promote gap junctional intercellular communication , 2013, Neuropeptides.

[5]  A. Shekhar,et al.  NPY Y1 Receptors Differentially Modulate GABAA and NMDA Receptors via Divergent Signal-Transduction Pathways to Reduce Excitability of Amygdala Neurons , 2013, Neuropsychopharmacology.

[6]  Zhuojing Luo,et al.  Overexpression of integrin a2 promotes osteogenic differentiation of hBMSCs from senile osteoporosis through the ERK pathway. , 2013, International journal of clinical and experimental pathology.

[7]  D. Walsh,et al.  A role for the sensory neuropeptide calcitonin gene‐related peptide in endothelial cell proliferation in vivo , 2012, British journal of pharmacology.

[8]  H. Haider,et al.  Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells. , 2011, Rejuvenation research.

[9]  N. Benvenisty,et al.  Molecular and Functional Characterizations of Gastrula Organizer Cells Derived from Human Embryonic Stem Cells , 2011, Stem cells.

[10]  A. Rubinacci,et al.  Calcitonin gene‐related peptide (CGRP) inhibits apoptosis in human osteoblasts by β‐catenin stabilization , 2010, Journal of cellular physiology.

[11]  G. Pei,et al.  Different effects of implanting vascular bundles and sensory nerve tracts on the expression of neuropeptide receptors in tissue-engineered bone in vivo , 2010, Biomedical materials.

[12]  Estrela Neto,et al.  Neuropeptide Y and osteoblast differentiation – the balance between the neuro‐osteogenic network and local control , 2010, The FEBS journal.

[13]  P. Baldock,et al.  Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  H. Herzog,et al.  NPY regulation of bone remodelling , 2009, Neuropeptides.

[15]  Xi Jiang,et al.  Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity , 2009, Journal of cellular biochemistry.

[16]  M. Sousa,et al.  NPY revealed as a critical modulator of osteoblast function in vitro: New insights into the role of Y1 and Y2 receptors , 2009, Journal of cellular biochemistry.

[17]  C. Jacobs,et al.  Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. , 2009, Bone.

[18]  Xi He,et al.  Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.

[19]  M. Jaber,et al.  Neuropeptide Y stimulates proliferation, migration and differentiation of neural precursors from the subventricular zone in adult mice , 2009, Neurobiology of Disease.

[20]  J. Eisman,et al.  Critical Interplay Between Neuropeptide Y and Sex Steroid Pathways in Bone and Adipose Tissue Homeostasis , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  L. Dai,et al.  Changes of substance P-immunoreactive nerve fiber innervation density in the sublesional bones in young growing rats at an early stage after spinal cord injury , 2008, Osteoporosis International.

[22]  J. Eisman,et al.  Novel Role of Y1 Receptors in the Coordinated Regulation of Bone and Energy Homeostasis* , 2007, Journal of Biological Chemistry.

[23]  J. Eisman,et al.  Greater Bone Formation of Y2 Knockout Mice Is Associated with Increased Osteoprogenitor Numbers and Altered Y1 Receptor Expression* , 2007, Journal of Biological Chemistry.

[24]  J. P. Hobson,et al.  Neuropeptide Y induces migration , proliferation , and tube formation of endothelial cells bimodally via Y 1 , Y 2 , and Y 5 receptors , 2006 .

[25]  R. Baron,et al.  Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  O. MacDougald,et al.  Regulation of bone mass by Wnt signaling. , 2006, The Journal of clinical investigation.

[27]  S. Roman-Roman,et al.  Wnt signalling pathway: a new target for the treatment of osteoporosis , 2005, Expert opinion on therapeutic targets.

[28]  J. A. Robinson,et al.  High Bone Mass in Mice Expressing a Mutant LRP5 Gene , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  P. Mantyh,et al.  Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur , 2002, Neuroscience.

[30]  Y. Matsusue,et al.  Neuronal regulation of bone metabolism and anabolism: Calcitonin gene‐related peptide‐, substance P‐, and tyrosine hydroxylase‐containing nerves and the bone , 2002, Microscopy research and technique.

[31]  Ivan Lobov,et al.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.

[32]  G. Ronnett,et al.  Neuropeptide Y functions as a neuroproliferative factor , 2001, Nature.

[33]  A. Mantovani,et al.  Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.